Menu Search
Equities

Burcon NutraScience Corp

BNE:FRA

Burcon NutraScience Corp

Actions
  • Price (EUR)0.088
  • Today's Change0.00 / 0.00%
  • Shares traded23.00k
  • 1 Year change-2.87%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Burcon NutraScience Corporation is a Canada-based global technology company focused on the development of plant-based proteins for foods and beverages. The Company has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The Company is engaged in the production of hemp protein isolate and provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. It extracts and purifies a canola protein isolate from canola meal. It has branded this protein isolate under the trade name Puratein C. Peazazz is a soluble, clean and neutral-tasting pea protein. It provides consulting and contract services, product and process development, and process scale-up and validation.

  • Revenue in CAD (TTM)420.98k
  • Net income in CAD-7.40m
  • Incorporated1998
  • Employees18.00
  • Location
    Burcon NutraScience Corp1946 Broadway WVANCOUVER V6J 1Z2CanadaCAN
  • Phone+1 (604) 733-0896
  • Fax+1 (604) 733-0896
  • Websitehttps://www.burcon.ca/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.